心臟再同步治療 (CRT) 設備的全球市場

Cardiac Resynchronization Therapy (CRT) Devices

出版日期: 2024年09月01日 | 出版商:

Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球心臟再同步治療 (CRT) 設備市場預計將達到 109 億美元

心臟再同步治療 (CRT) 設備的全球市場預計 2023 年為 65 億美元，預計到 2030 年將達到 109 億美元，在 2023-2030 年分析期間複合年成長率為 7.7%。 CRT心臟去顫器（CRT-D）是本報告分析的細分市場之一，複合年成長率為7.4%，預計到分析期結束時將達到78億美元。在分析期間，CRT心律調節器(CRT-P) 細分市場的複合年成長率預計為 8.4%。

美國市場預估成長18億美元，中國複合年成長率7.3%

預計 2023 年美國心臟再同步治療 (CRT) 設備市場規模將達 18 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達17億美元，2023-2030年分析期間複合年成長率為7.3%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間複合年成長率分別為 7.0% 和 6.6%。在歐洲，德國預計複合年成長率為 7.2%。

全球心臟再同步治療 (CRT) 設備市場 - 主要趨勢和促進因素總結

什麼是心臟再同步治療 (CRT) 設備？

心臟再同步治療 (CRT) 設備是治療心臟衰竭的重要工具，特別是對於患有電傳導障礙、損害心臟有效跳動能力的患者。這些設備旨在恢復心室的協調收縮並提高整體幫浦效率。 CRT 機器通常由心律調節器或植入式心臟整流去顫器(ICD) 組成，其導線放置在心臟的兩個心室中。透過向心室發送同步電脈衝，CRT 機器可以糾正心臟衰竭或束支傳導阻滯患者常見的心率失調。這種治療方法通常用於對常規治療方法沒有充分反應的中度至重度心臟衰竭患者。 CRT的最終目標是減少呼吸急促和疲勞等心臟衰竭症狀，提高生活品質，並降低住院和死亡風險。心臟衰竭影響全世界數百萬人，CRT 設備是治療這種慢性且常常使人衰弱的疾病的重要介入措施。

哪些技術可以提高 CRT 設備的效率？

CRT 設備的技術進步顯著提高了其有效性、安全性和整體患者體驗。該領域的主要進展之一是自適應 CRT 系統的開發，該系統可根據患者的活動水平和心律自動調整起搏。這些系統利用複雜的演算法，透過在各種條件下（包括休息時和運動時）使心跳盡可能高效來最佳化治療。另一項重大創新是遠端監控功能的整合，允許將患者資料即時傳輸給醫療保健提供者。這使得臨床醫生能夠持續監測設備性能和患者心臟狀態，而無需頻繁就診。遠端監控不僅可以透過及時協調治療來改善患者的治療效果，還可以減少住院和緊急介入的需要。此外，CRT 機器的小型化使其侵入性更小，患者更舒適。這些小型、高效的設備具有更長的電池壽命，並且更容易植入，從而降低了手術期間出現併發症的風險。 CRT 設備中的無線技術允許設備和外部監測系統之間的無縫通訊，進一步改善患者照護。隨著技術的進步，CRT 設備在心臟衰竭治療中的準確性和有效性有望提高，從而為患者帶來更好的治療結果。

心臟再同步治療設備的主要市場趨勢是什麼？

心臟再同步治療設備市場是由技術進步、人口變化和醫療保健服務變化所形成的幾個關鍵趨勢所推動的。最顯著的趨勢之一是全球心臟衰竭盛行率不斷增加。這主要是由於人口老化和導致心臟衰竭的疾病發生率不斷增加，例如高血壓、糖尿病和冠狀動脈疾病。因此，對 CRT 設備作為對單獨藥物治療沒有反應的患者的治療選擇的需求正在增加。另一個主要趨勢是擴大採用遠端患者監護解決方案。隨著醫療保健系統不斷成為數位平台，具有遠端監控功能的 CRT 設備變得越來越普遍。這不僅改善了患者管理，而且符合遠端醫療和居家醫療的全球趨勢。此外，CRT 設備的小型化和無引線版本正在被開拓，透過降低設備的侵入性並減少與引線相關的併發症的可能性，有望徹底改變市場。這些創新設備的監管核准正在加速，特別是在北美和歐洲等已開發地區，監管機構正在簡化流程，以便更快為患者提供救生技術。最後，一些地區擴大醫療保險覆蓋範圍和報銷政策，使 CRT 設備更容易獲得並受到更多患者的歡迎。

CRT設備市場擴大背後的因素有哪些？

心臟再同步治療設備市場的成長是由與技術進步、不斷變化的醫療保健趨勢和不斷變化的患者人口統計相關的幾個關鍵因素所推動的。一個主要促進因素是全球整體心臟衰竭盛行率不斷上升，特別是隨著人口老化。隨著心臟衰竭患者數量的不斷增加，對 CRT 等有效治療方案的需求也在增加，這對於對傳統心臟衰竭治療沒有反應的患者尤其重要。 CRT技術的不斷進步，包括自適應CRT設備的開發和遠端監控功能的整合，顯著增加了這些設備的吸引力。自適應系統可根據患者的特定需求自動調整起搏參數，進而提高治療效果並降低併發症的可能性。此外，遠端醫療和遠端患者監護的普及正在推動對能夠無縫傳輸資料的 CRT 設備的需求，從而能夠更主動、更有效率地管理心臟衰竭患者。 COVID-19 大流行進一步加速了向居家醫療的轉變，凸顯了遠端監測在慢性病管理中的重要性。另一個促進因素是擴大關注減少再入院和改善長期結果，以及醫療保健系統採用基於價值的照護模式。 CRT 可以改善心臟功能並減少緊急干預的需要，從而滿足了這些醫療保健目標。此外，更小的設備尺寸和更長的電池壽命使 CRT 設備更易於使用、侵入性更小、更耐用，從而提高了患者滿意度和整體採用率。最後，有利的監管政策和醫療保險的擴張，特別是在新興市場，正在促進患者獲得救生設備，進一步推動市場成長。

受訪企業範例（42家知名企業）

Abbott Cardiovascular
Biotronik SE & Co. KG
Boston Scientific Corporation
EBR Systems, Inc.
Lepu Medical Technology（Beijing）Co., Ltd.
LivaNova PLC
Medico SpA
Medtronic Plc
MicroPort Scientific Corporation
Osypka Medical GmbH

The global market for Cardiac Resynchronization Therapy (CRT) Devices estimated at US$6.5 Billion in the year 2023, is expected to reach US$10.9 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. CRT-Defibrillator (CRT-D), one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$7.8 Billion by the end of the analysis period. Growth in the CRT-Pacemaker (CRT-P) segment is estimated at 8.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.8 Billion While China is Forecast to Grow at 7.3% CAGR

The Cardiac Resynchronization Therapy (CRT) Devices market in the U.S. is estimated at US$1.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 7.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.0% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.

Global Cardiac Resynchronization Therapy (CRT) Devices Market - Key Trends and Drivers Summarized

What Are Cardiac Resynchronization Therapy (CRT) Devices and Why Are They Essential?

Cardiac Resynchronization Therapy (CRT) devices are critical tools in the management of heart failure, particularly for patients suffering from electrical conduction problems that impair the heart’s ability to beat efficiently. These devices are designed to restore the coordinated contraction of the heart's ventricles, improving its overall pumping efficiency. CRT devices typically consist of a pacemaker or an implantable cardioverter-defibrillator (ICD) equipped with leads that are placed in both ventricles of the heart. By delivering synchronized electrical pulses to the ventricles, CRT devices correct the misalignment in heartbeats that is common in patients with heart failure or bundle branch block. This form of therapy is often prescribed for individuals who have moderate to severe heart failure and who have not responded well to conventional treatments. The ultimate goal of CRT is to reduce the symptoms of heart failure, such as shortness of breath and fatigue, improve the quality of life, and lower the risk of hospitalization or death. With heart failure affecting millions of people worldwide, CRT devices represent a vital intervention in the management of this chronic and often debilitating condition.

How Is Technology Enhancing the Effectiveness of CRT Devices?

The technological evolution of CRT devices has significantly enhanced their effectiveness, safety, and the overall patient experience. One of the key advancements in this field has been the development of adaptive CRT systems that automatically adjust pacing based on a patient’s activity levels and heart rhythms. These systems utilize sophisticated algorithms to optimize therapy by ensuring the heart beats as efficiently as possible under various conditions, such as rest or exercise. Another major innovation is the integration of remote monitoring capabilities, allowing real-time transmission of patient data to healthcare providers. This enables clinicians to continuously monitor the performance of the device and the patient's heart condition without the need for frequent in-person visits. Remote monitoring not only improves patient outcomes through timely adjustments in therapy but also reduces the need for hospitalizations and emergency interventions. Additionally, the miniaturization of CRT devices has made them less invasive and more comfortable for patients. These smaller, more efficient devices now have longer battery lives and are easier to implant, reducing the risk of complications during surgery. The inclusion of wireless technology in CRT devices has further improved patient care, allowing for seamless communication between the device and external monitoring systems. As technology continues to advance, the precision and efficacy of CRT devices in treating heart failure are expected to grow, offering even better outcomes for patients.

What Are the Key Market Trends in Cardiac Resynchronization Therapy Devices?

Several important trends are driving the cardiac resynchronization therapy devices market, shaped by advancements in technology, demographic shifts, and changes in healthcare delivery. One of the most notable trends is the increasing prevalence of heart failure globally, largely driven by aging populations and the rising incidence of conditions such as hypertension, diabetes, and coronary artery disease, all of which contribute to the onset of heart failure. This has fueled the demand for CRT devices as a treatment option for patients who are not responding to medications alone. Another key trend is the growing adoption of remote patient monitoring solutions. With healthcare systems increasingly moving towards digital platforms, CRT devices with remote monitoring capabilities are becoming more widespread. This not only improves patient management but also aligns with the global trend towards telemedicine and home-based care. Furthermore, the ongoing miniaturization of CRT devices and the development of leadless versions are set to revolutionize the market by making the devices less invasive and reducing the potential for lead-related complications. Regulatory approval of these innovative devices is accelerating, particularly in developed regions like North America and Europe, where regulatory agencies have streamlined processes to get these life-saving technologies to patients faster. Lastly, the expansion of healthcare coverage and reimbursement policies in several regions is making CRT devices more accessible to a broader patient population, driving increased adoption.

What Are the Factors Driving Expansion of the CRT Devices Market?

The growth in the cardiac resynchronization therapy devices market is driven by several key factors tied to advancements in technology, shifts in healthcare trends, and changing patient demographics. A primary driver is the rising prevalence of heart failure across the globe, particularly in aging populations. As the number of heart failure patients continues to increase, so does the demand for effective treatment options like CRT, which is especially critical for patients who do not respond to conventional heart failure therapies. The ongoing advancements in CRT technology, such as the development of adaptive CRT devices and the integration of remote monitoring capabilities, have significantly enhanced the appeal of these devices. Adaptive systems that automatically adjust pacing parameters based on patient-specific needs improve therapy effectiveness and reduce the likelihood of complications. Moreover, the widespread adoption of telemedicine and remote patient monitoring has boosted the demand for CRT devices that can seamlessly transmit data, allowing for more proactive and efficient management of heart failure patients. The shift toward home-based care, further accelerated by the COVID-19 pandemic, has emphasized the importance of remote monitoring in chronic disease management. Another driver is the increasing focus on reducing hospital readmissions and improving long-term outcomes, which has led healthcare systems to embrace value-based care models. CRT devices, by improving heart function and reducing the need for emergency interventions, align well with these healthcare goals. Additionally, advancements in device miniaturization and battery life are making CRT devices more accessible, less invasive, and more durable, leading to higher patient satisfaction and better overall adoption. Finally, favorable regulatory policies and expanding healthcare coverage, especially in developed markets, have made it easier for patients to access these life-saving devices, further fueling market growth.

Select Competitors (Total 42 Featured) -

Abbott Cardiovascular
Biotronik SE & Co. KG
Boston Scientific Corporation
EBR Systems, Inc.
Lepu Medical Technology (Beijing) Co., Ltd.
LivaNova PLC
Medico SpA
Medtronic Plc
MicroPort Scientific Corporation
Osypka Medical GmbH

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- Global Economic Update
- Cardiac Resynchronization Therapy (CRT) Devices - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Incidence of Heart Failure Throws the Spotlight on Cardiac Resynchronization Therapy (CRT) Devices
- Technological Advancements in CRT Devices Propel Growth in Heart Failure Treatment
- Increasing Use of Remote Monitoring Expands Addressable Market Opportunity for CRT Devices
- Growing Adoption of AI in Health Monitoring Spurs Demand for Smarter CRT Devices
- Integration of Telemedicine Generates New Opportunities for CRT Device Management
- Expanding Use of Advanced Imaging Techniques Drives Precision in CRT Device Implantation
- Rising Demand for Non-Invasive Monitoring Propels Growth in CRT Device Usage
- Innovations in Battery Longevity and Device Miniaturization Accelerate Demand for Next-Generation CRT Devices
- Increasing Need for Long-Term, Real-Time Monitoring Spurs Use of Advanced CRT Devices
- Advancements in Device Connectivity and Data Analytics Propel Growth of CRT Solutions
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Cardiac Resynchronization Therapy (CRT) Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 3: World Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 4: World 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for CRT-Defibrillator (CRT-D) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 6: World Historic Review for CRT-Defibrillator (CRT-D) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 7: World 16-Year Perspective for CRT-Defibrillator (CRT-D) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for CRT-Pacemaker (CRT-P) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 9: World Historic Review for CRT-Pacemaker (CRT-P) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 10: World 16-Year Perspective for CRT-Pacemaker (CRT-P) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Hospitals & Cardiac Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 12: World Historic Review for Hospitals & Cardiac Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 13: World 16-Year Perspective for Hospitals & Cardiac Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 17: USA Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 18: USA Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 19: USA 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 20: USA Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 21: USA Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 22: USA 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
CANADA
- TABLE 23: Canada Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 24: Canada Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 25: Canada 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 26: Canada Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 27: Canada Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 28: Canada 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
JAPAN
- Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 29: Japan Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 30: Japan Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 31: Japan 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 32: Japan Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 33: Japan Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 34: Japan 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
CHINA
- Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 35: China Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 36: China Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 37: China 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 38: China Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 39: China Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 40: China 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
EUROPE
- Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 41: Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 42: Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 43: Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
- TABLE 44: Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 45: Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 46: Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 47: Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 48: Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 49: Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
FRANCE
- Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 50: France Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 51: France Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 52: France 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 53: France Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 54: France Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 55: France 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
GERMANY
- Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 56: Germany Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 57: Germany Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 58: Germany 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 59: Germany Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 60: Germany Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 61: Germany 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
ITALY
- TABLE 62: Italy Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 63: Italy Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 64: Italy 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 65: Italy Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 66: Italy Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 67: Italy 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 68: UK Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 69: UK Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 70: UK 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 71: UK Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 72: UK Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 73: UK 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
REST OF EUROPE
- TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 75: Rest of Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 76: Rest of Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 78: Rest of Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 79: Rest of Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 81: Asia-Pacific Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 82: Asia-Pacific 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 84: Asia-Pacific Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 85: Asia-Pacific 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
REST OF WORLD
- TABLE 86: Rest of World Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 87: Rest of World Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 88: Rest of World 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 89: Rest of World Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 90: Rest of World Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 91: Rest of World 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030